Showing results (301-310 of 3,787) with videos related to
Sort By:
Pageof 379
Oncoimmunology|June 7, 2018
Spontaneous T-cell responses against the immune check point programmed-death-ligand 1 (PD-L1) in patients with chronic myeloproliferative neoplasms correlate with disease stage and clinical responseMorten Orebo Holmström, Caroline Hasselbalch Riley, Vibe Skov, et al.Oncoimmunology|June 7, 2018
Cellular immunotherapy on primary multiple myeloma expanded in a 3D bone marrow niche modelMaaike V J Braham, Monique C Minnema, Tineke Aarts, et al.Oncoimmunology|June 7, 2018
The role of Galectin-3 in modulating tumor growth and immunosuppression within the tumor microenvironmentMohammad Farhad, Annah S Rolig, William L RedmondOncoimmunology|June 7, 2018
Adenoviral vectors transduce alveolar macrophages in lung cancer modelsDarinee D Tippimanchai, Kyle Nolan, Joanna Poczobutt, et al.Oncoimmunology|June 7, 2018
High mobility group box 1 (HMGB1) acts as an "alarmin" to promote acute myeloid leukaemia progressionInna M Yasinska, Isabel Gonçalves Silva, Svetlana S Sakhnevych, et al.Oncoimmunology|June 23, 2018
Gemcitabine alters the proteasome composition and immunopeptidome of tumour cellsA M Gravett, N Trautwein, S Stevanović, et al.Oncoimmunology|April 17, 2023
Immunotherapy with IL12 and PD1/CTLA4 inhibition is effective in advanced ovarian cancer and associates with reversal of myeloid cell-induced immunosuppressionPaul G Pavicic, Patricia A Rayman, Shadi Swaidani, et al.Oncoimmunology|April 2, 2021
Association of circulating protein biomarkers with clinical outcomes of durvalumab in head and neck squamous cell carcinomaRosalinda Arends, Xiang Guo, Paul G Baverel, et al.Oncoimmunology|April 2, 2021
Crystal structure of human interleukin-2 in complex with TCB2, a new antibody-drug candidate with antitumor activityJieun Kim, Jun-Young Lee, Suk-Youl Park, et al.Oncoimmunology|May 4, 2023
Phenotypic characterization of spatial immune infiltration niches in non-small cell lung cancerAnna Sandström Gerdtsson, Mattis Knulst, Johan Botling, et al.Pageof 379